Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...

Health Alzheimer's Disease study plans to study 2,000 volunteers' brain scans and blood work to identify biomarkers of ...

Scientists may have uncovered a new mechanism for treating Alzheimer's disease, offering hope to millions of patients worldwide. The discovery involves the activation of the brain's cellular clean-up ...

Neurophet has specialized in developing solutions for diagnosis support, treatment guides, and treatment devices targeting ...

The approved drugs for Alzheimer’s disease do not address the underlying cause of the disease, but instead treat only the symptoms. However, there is a vast array of experimental treatments that are ...

Oct. 16, 2024 — Researchers used mouse models and human post-mortem brain tissue to study the molecular underpinnings that may increase the risk of Alzheimer's after ... Alzheimer's Disease May ...

In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...

Aricept is approved for all stages of AD, while Razadyne and Exelon are approved for the treatment of mild-to-moderate AD. Alzheimer’s damages cells that produce acetylcholine, which reduces the ...

As the need for new Alzheimer's treatments grows, the market will become more crowded for pharma companies and segmentation will become an ever more useful tool in market research, drug ...

29, 2024 — Researchers are searching for a better way to understand why many men with prostate cancer end up with Alzheimer's disease, and whether it's the standard hormone therapy treatment or an ...